• Profile
Close

Fluid restriction therapy for chronic SIAD; Results of a prospective randomized controlled trial

Journal of Clinical Endocrinology & Metabolism Oct 06, 2020

Garrahy A, Galloway I, Hannon AM, et al. - Researchers conducted this prospective nonblinded randomized controlled trial to analyze fluid restriction (FR) compared with no treatment in a chronic syndrome of inappropriate antidiuresis (SIAD). In total, 46 patients with chronic asymptomatic SIAD have been randomized to either FR (1 liter/day) or no specific hyponatremia treatment (NoTx) for 1 month. In patients with chronic SIAD, FR induces a modest early increase in pNa, with limited additional increase thereafter, and is well-tolerated. After 3 days of FR, more than one-third of patients fail to reach a pNa ≥130 mmol/L, highlighting the clinical need for additional SIAD therapies in certain patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay